-transparent.png){kind=logo}
3'-Deamino-4'-epi-3'-hydroxy-daunorubicin (11) and -doxorubicin (14) have been synthesized. In the in vivo murine P-388 lymphocytic leukemia assay, these two compounds were more active than daunorubicin (1) and doxorubicin (2), respectively. Comparative studies in the P-388 assay indicated 3'-deamino-3'-hydroxydoxorubicin (3) to be more active than its 4'-epimer 14.
Related Publications
D Horton, and
W Priebe, and
O Varela
January 1985,
Carbohydrate research,
D Horton, and
W Priebe, and
O Varela
July 1999,
Carbohydrate research,
D Horton, and
W Priebe, and
O Varela
October 1992,
Journal of medicinal chemistry,
D Horton, and
W Priebe, and
O Varela
October 1986,
Journal of medicinal chemistry,
D Horton, and
W Priebe, and
O Varela
April 1982,
Tumori,
D Horton, and
W Priebe, and
O Varela
February 1979,
Journal of medicinal chemistry,
D Horton, and
W Priebe, and
O Varela
April 1994,
Anti-cancer drug design,
D Horton, and
W Priebe, and
O Varela
June 2006,
Bioorganic & medicinal chemistry letters,
D Horton, and
W Priebe, and
O Varela
December 1998,
Bioorganic & medicinal chemistry letters,
D Horton, and
W Priebe, and
O Varela
January 1991,
Anticancer research,
